For the quarter ending October 2025, The Cooper Companies (COO) reported revenue of $1.07 billion, up 4.6% compared to the same period last year. EPS came to $1.15, compared to $1.04 in the same quarter last year.
Reported revenues compare to the Zacks Consensus Estimate of $1.06 billion, representing a surprise of +0.45%. The company delivered an EPS surprise of +3.6%, with a consensus EPS estimate of $1.11.
As investors examine year-over-year changes in revenue and earnings and how they compare to Wall Street forecasts to determine their next move, a few key metrics always provide a more accurate picture of a company’s financial health.
Since these metrics play a crucial role in driving the top and bottom numbers, comparing them to last year’s numbers and what analysts estimate about them helps investors better predict stock price performance.
Here’s how The Cooper Companies performed in the just-reported quarter in terms of metrics widely watched and forecast by Wall Street analysts:
- Revenue by Geography – Americas: $285.1 million, compared to $291.49 million according to average estimates by two analysts. Compared to the same quarter last year, this figure represents a change of +5.4%.
- Revenue by Geography – Asia Pacific: $147.4 million versus the average analyst estimate of $139.8 million. The reported figure represents a year-over-year change of -1.3%.
- Revenue by Geography – Europe, Middle East and Africa: $277.1 million versus the average analyst estimate of $269.49 million. The reported figure represents a year-over-year change of +8%.
- Revenue by Category – CVI: $709.6 million compared to the average estimate of $707.83 million based on five analysts. The reported figure represents a change of +4.9% year over year.
- Revenue by Category – CSI: $355 million, compared to $352.65 million according to average estimates by five analysts. Compared to the same quarter last year, this figure represents a change of +3.8%.
- Revenue by Category – CSI – Office & Surgical: $214.6 million, compared to $208.89 million according to the average estimates of four analysts. Compared to the same quarter last year, this figure represents a change of +5.8%.
- Revenue by Category – CSI – Fertility: $141 million compared to the average estimate of $144.03 million based on four analysts. The reported figure represents a change of +1.3% year over year.
- Revenue by Category – CVI – Industry, Other: $365 million compared to the average estimate of $362.34 million based on four analysts. The reported figure represents a change of +3.3% year over year.
- Revenue by Category- CVI- Toric and Multifocal: $344.6 million, compared to $346.45 million according to the average estimates of four analysts. Compared to the same quarter last year, this figure represents a change of +6.6%.
Want the latest recommendations from Zacks Investment Research? Download the 7 best stocks for the next 30 days. Click to get this free report


